Overview

Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients

Status:
Withdrawn

Trial end date:
2023-02-01

Target enrollment:

Participant gender:

Summary

A phase II, prospective, multicentre, single-blinded, randomised study (when fentanyl citrate is used outside of its marketing authorisation) Patients will be enrolled in an observational cohort when the fentanyl citrate is used according to its marketing authorisation.

Phase:

Phase 2

Details

Lead Sponsor:

UNICANCER

Treatments:

Citric Acid
Fentanyl